lapatinib has been researched along with carbenoxolone sodium in 1 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (carbenoxolone sodium) | Trials (carbenoxolone sodium) | Recent Studies (post-2010) (carbenoxolone sodium) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 1,084 | 79 | 313 |
Protein | Taxonomy | lapatinib (IC50) | carbenoxolone sodium (IC50) |
---|---|---|---|
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.9055 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.9498 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
1 other study(ies) available for lapatinib and carbenoxolone sodium
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |